S J M Neele

Summary

Country: The Netherlands

Publications

  1. ncbi Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women
    S J M Neele
    Endocrinology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    Bone 30:599-603. 2002
  2. ncbi Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women
    T Teerlink
    Department of Clinical Chemistry, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Clin Sci (Lond) 105:67-71. 2003

Detail Information

Publications2

  1. ncbi Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women
    S J M Neele
    Endocrinology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    Bone 30:599-603. 2002
    ..Our results show that 5 years of treatment with either Ral or CEE did not protect against bone loss after 1 year of withdrawal of therapy, and that the rate of bone loss was not significantly different from that of placebo-treated women...
  2. ncbi Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women
    T Teerlink
    Department of Clinical Chemistry, VU University Medical Center, P O Box 7057, 1007 MB Amsterdam, The Netherlands
    Clin Sci (Lond) 105:67-71. 2003
    ..Thus ERT with oral conjugated oestrogen, but not with raloxifene, significantly reduced plasma concentrations of the cardiovascular risk factor ADMA in healthy postmenopausal women...